Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$484,066
+$10,831 QoQ
Shares Held
1,906
-1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.73%
of 13F equity value
Holder Rank
#3,737
of 4,676 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Flagstone Financial Management holds $703,518 across 2 Drug Manufacturers - General names. JNJ ranks #1 (68.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
1,906 | $484,066 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
1,737 | $219,452 |
All Filings in JNJ
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $484,066 | 1,906 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $473,235 | 1,936 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $374,786 | 1,811 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $205,816 | 1,110 | Shares | Sole | 2025-10-31 | |
| No filing history on record for this holder in this stock. | ||||||